Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Journal of Hepatology|April 1, 1987
Gastro-oesophageal reflux and alcoholic cirrhosis. A reappraisalD Arsene, S Bruley des Varannes, J P Galmiche, et al.
Neurogastroenterology and Motility|September 1, 2017
Modulation of VIPergic phenotype of enteric neurons by colonic biopsy supernatants from patients with inflammatory bowel diseases: Involvement of IL-6 in Crohn's diseaseF Soufflet, M Biraud, M Rolli-Derkinderen, et al.
Alimentary Pharmacology & Therapeutics|February 16, 2011
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux diseaseF Zerbib, S Bruley des Varannes, S Roman, et al.
Alimentary Pharmacology & Therapeutics|July 22, 2014
Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applicationsY Touchefeu, E Montassier, K Nieman, et al.
Gut|August 18, 2005
Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundusS Bruley des Varannes, J Chevalier, S Pimont, et al.
Gastroenterology|August 1, 1996
Colonic fermentation and proximal gastric tone in humansA Ropert, C Cherbut, C Rozé, et al.
Neurogastroenterology and Motility|December 17, 2008
Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental ParkinsonismT Chaumette, T Lebouvier, P Aubert, et al.
Gastroenterologie Clinique Et Biologique|August 1, 1987
[Campylobacter pylori and gastric mucosa: histological and bacteriological study and preliminary results of an epidemiological survey in the area of Nantes]M F Le Bodic, P Barré, C Freland, et al.
Medecine Et Maladies Infectieuses|April 4, 2016
Community-acquired Clostridium difficile infectionsA Penit, P Bemer, J Besson, et al.
Neurogastroenterology and Motility|March 25, 2017
The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux diseaseM-L Rouzade-Dominguez, N Pezous, O J David, et al.
Pageof 9